neladalkib   Click here for help

GtoPdb Ligand ID: 13214

Synonyms: compound 1 [WO2023196910]
PDB Ligand
Compound class: Synthetic organic
Comment: The chemical structure for neladalkib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as an anaplastic lymphoma kinase (ALK) inhibitor with potential antineoplastic action. It is claimed in Nuvalent's patent WO2023196910 [1]. Nuvalent's pipeline declares one ALK inhibitor, NVL-655, so we suspect that this may be neladalkib.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 78.81
Molecular weight 452.91
XLogP 2.41
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN1C2=C(CC3=CN(C)N=C3C4=CC=C(C=C4[C@@H](C)OC5=CC2=CN=C5N)F)C(=N1)Cl
Isomeric SMILES CCN1C2=C(CC3=CN(N=C3C4=C(C=C(C=C4)F)[C@H](OC5=C(N=CC2=C5)N)C)C)C(=N1)Cl
InChI InChI=1S/C23H22ClFN6O/c1-4-31-21-13-8-19(23(26)27-10-13)32-12(2)17-9-15(25)5-6-16(17)20-14(11-30(3)28-20)7-18(21)22(24)29-31/h5-6,8-12H,4,7H2,1-3H3,(H2,26,27)/t12-/m1/s1
InChI Key FWZSCAQEBTVTOM-GFCCVEGCSA-N
Classification Click here for help
Compound class Synthetic organic
International Nonproprietary Names Click here for help
INN number INN
12898 neladalkib
Synonyms Click here for help
compound 1 [WO2023196910]
Database Links Click here for help
CAS Registry No. 2739866-40-9 (source: WHO INN record)
GtoPdb PubChem SID 491299996
PubChem CID 164718816
RCSB PDB Ligand A1IJ8
Search Google for chemical match using the InChIKey FWZSCAQEBTVTOM-GFCCVEGCSA-N
Search Google for chemicals with the same backbone FWZSCAQEBTVTOM
Search PubMed clinical trials neladalkib
Search PubMed titles neladalkib
Search PubMed titles/abstracts neladalkib
UniChem Compound Search for chemical match using the InChIKey FWZSCAQEBTVTOM-GFCCVEGCSA-N
UniChem Connectivity Search for chemical match using the InChIKey FWZSCAQEBTVTOM-GFCCVEGCSA-N